Foghorn Therapeutics: BVF Partners LP group reports 10% owner stake
Foghorn Therapeutics' initial beneficial ownership filing showed BVF Partners LP group reporting as a 10% owner as of October 1, 2026. The group disclosed direct ownership of 8,346,168 common shares and warrants for an additional 9,512,297 shares.